It’s time to acknowledge that we are “aware,” it’s time to rebrand October as the month for more relevant breast cancer ...

Zymeworks Inc. (Nasdaq: ZYME) a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat ...

SAN FRANCISCO and SUZHOU, China, Sept. 17, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...

Medicaid cancer foundation, on behalf of the International Gynecologic Cancer Society (IGCS), has announced that Dr. Zainab ...

Merck's Keytruda scored two important victories in women's cancer, according to presentations Sunday at the ESMO meeting.

Management will discuss the advantages of the Company’s 3S TCRs across a wide range of modalities, including TCR-engineered T cell (TCR-T) therapies, TCR-guided T cell engager therapies (TCR-TCE), and ...

Between June 5 and December 12, 2023, ten adult patients with advanced ccRCC who received a median of four prior treatment lines (range: 2-7) were enrolled and received a median of three cycles (range ...

It’s hard for practicing oncologists to stay on top of the latest clinical data, but good partnerships and clinical decision ...

The National Comprehensive Cancer Network Policy Summit emphasized the importance of integrating diversity, equity, and ...

Shirish M. Gadgeel, MD, discusses research that he is particularly excited to see presented at the 2024 European Society for ...

Pfizer Inc. (NYSE: PFE) continues to showcase potential practice-changing research and next-generation candidates across its robust Oncology portfolio at the European Society for Medical Oncology ...